논문KCI 등재
Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
2
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (10)
- 심재준, "Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions", Gut and Liver, 9(3), pp.265~266 (2015), 거트앤리버 발행위원회
- 권정현, "The Efficacy and Safety of Peginterferon-α-2a in Korean Patients with Chronic Hepatitis B: A Multicenter Study Conducted in a Real Clinical Setting", Gut and Liver, 7(2), pp.197~205 (2013), 거트앤리버 발행위원회
- Lau GK, "Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B", N Engl J Med, 352, pp.2682~2695 (2005)
- Janssen HL, "Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial", Lancet, 365, pp.123~129 (2005)
- Chung-Il Wi, "Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B", Gut and Liver, 10(4), pp.611~616 (2016), 거트앤리버 발행위원회
- Thimme R, "Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B?", J Hepatol, 58, pp.205~209 (2013)
- Marcellin P, "HBsAg loss with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2a (PEG) in chronic hepatitis B (CHB): results of a global randomized controlled trial", Hepatology, 60(1), pp.294A~295A (2014)
- Su WW, "O113 Combination therapy with peginterferon alfa-2a and a nucleos(t)ide analogue for HBeAgpositive chronic hepatitis B patients: results of a large, randomised, multicentre, double-blind, placebo-controlled study", J Hepatol, 60(1), pp.S47~ (2014)
- Ning Q, "Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial)", J Hepatol, 61, pp.777~784 (2014)
- Brouwer WP, "Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: a multicenter randomized trial (ARES study)", Hepatology, 61, pp.1512~1522 (2015)
관련 논문AI추천
Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis BChung-Il Wi, John B. Gross, Jr, John J. Poterucha, Linda M. Stadheim, W. Ray Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제4호Combination Therapy for Chronic Hepatitis B: Current Updates and PerspectivesChun-Jen Liu, Tung-Hung Su거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제5호Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions심재준거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제3호Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?Byoung Kuk Jang대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제3호Toward a Functional Cure for Hepatitis BRay Gautam거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제4호Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B조성원, Jae Youn Cheong, Soon Sun Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2011 · 제5권 제3호
이 간행물의 다른 논문 (28건)
The Efficiency of Intravenous Iron Therapy in Korean Inflammatory Bowel Disease PatientsKyeong Ok Kimpp. 487-488Is Elderly Age a Simple Predictive Factor for Inadequate Bowel Preparation before Colonoscopy?Hyun Gun Kimpp. 489-490Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel DisSeong-Eun Kimpp. 491-492Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection김유선, Jung Hwa Minpp. 493-494Towards Steroid-Free Immunosuppression after Liver TransplantationShawn J. Pelletier, Victor M. Zaydfudimpp. 495-496
